EP0614364A4 - Methods and compositions for treating infection using optically pure (s)-lomefloxacin. - Google Patents

Methods and compositions for treating infection using optically pure (s)-lomefloxacin.

Info

Publication number: EP0614364A4
Authority: EP; European Patent Office
Prior art keywords: lomefloxacin; compositions; methods; optically pure; treating infection
Prior art date: 1991-11-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

EP9292925403A

Other languages

German (de)

French (fr)

Other versions

EP0614364A1 (en

Inventor

James W Young

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sunovion Pharmaceuticals Inc

Original Assignee

Sepracor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-27

Filing date

1992-11-25

Publication date

1994-10-19

1992-11-25 Application filed by Sepracor Inc filed Critical Sepracor Inc

1994-09-14 Publication of EP0614364A1 publication Critical patent/EP0614364A1/en

1994-10-19 Publication of EP0614364A4 publication Critical patent/EP0614364A4/en

Status Ceased legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP9292925403A 1991-11-27 1992-11-25 Methods and compositions for treating infection using optically pure (s)-lomefloxacin. Ceased EP0614364A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US799243		1985-11-18
US79924391A	1991-11-27	1991-11-27
PCT/US1992/010142 WO1993010785A1 (en)	1991-11-27	1992-11-25	Methods and compositions for treating infection using optically pure (s)-lomefloxacin

Publications (2)

Publication Number	Publication Date
EP0614364A1 EP0614364A1 (en)	1994-09-14
EP0614364A4 true EP0614364A4 (en)	1994-10-19

Family

ID=25175406

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP9292925403A Ceased EP0614364A4 (en)	1991-11-27	1992-11-25	Methods and compositions for treating infection using optically pure (s)-lomefloxacin.

Country Status (5)

Country	Link
EP (1)	EP0614364A4 (en)
JP (1)	JPH07503457A (en)
AU (2)	AU3147493A (en)
CA (1)	CA2124443A1 (en)
WO (1)	WO1993010785A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6075024A (en) *	1991-11-27	2000-06-13	Sepracor Inc.	Methods for treating infection using optically pure (S)-lomefloxacin

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0140116A1 (en) *	1983-09-19	1985-05-08	Hokuriku Pharmaceutical Co.,Ltd	A 6-fluoro-1,4-dihydro-4-oxo-7-substituted piperazinyl-quinoline-3-carboxylic acid derivative and the method for preparing the same
JPS60190777A (en) *	1984-03-12	1985-09-28	Hokuriku Seiyaku Co Ltd	Optical active 6,8-difluoro-1,4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acid derivative
JPH01242582A (en) *	1988-03-22	1989-09-27	Hokuriku Seiyaku Co Ltd	Production of type i crystal of quinolone-carboxylic acid compound
JPH02115182A (en) *	1988-10-21	1990-04-27	Yoshitomi Pharmaceut Ind Ltd	Optically active pyridone-carboxylic acid compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS618538A (en) *	1984-06-25	1986-01-16	Shimizu Constr Co Ltd	Air conditioning mechanism in factory or the like

1992
- 1992-11-25 CA CA002124443A patent/CA2124443A1/en not_active Abandoned
- 1992-11-25 EP EP9292925403A patent/EP0614364A4/en not_active Ceased
- 1992-11-25 AU AU31474/93A patent/AU3147493A/en not_active Abandoned
- 1992-11-25 JP JP5510220A patent/JPH07503457A/en active Pending
- 1992-11-25 WO PCT/US1992/010142 patent/WO1993010785A1/en not_active Application Discontinuation
1997
- 1997-03-07 AU AU15151/97A patent/AU1515197A/en not_active Abandoned

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0140116A1 (en) *	1983-09-19	1985-05-08	Hokuriku Pharmaceutical Co.,Ltd	A 6-fluoro-1,4-dihydro-4-oxo-7-substituted piperazinyl-quinoline-3-carboxylic acid derivative and the method for preparing the same
US4528287A (en) *	1983-09-19	1985-07-09	Hokuriku Pharmaceutical Co., Ltd.	6-Fluoro-1, 4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acids and the method for preparing the same
JPS60190777A (en) *	1984-03-12	1985-09-28	Hokuriku Seiyaku Co Ltd	Optical active 6,8-difluoro-1,4-dihydro-4-oxo-7-substituted piperazinylquinoline-3-carboxylic acid derivative
JPH01242582A (en) *	1988-03-22	1989-09-27	Hokuriku Seiyaku Co Ltd	Production of type i crystal of quinolone-carboxylic acid compound
JPH02115182A (en) *	1988-10-21	1990-04-27	Yoshitomi Pharmaceut Ind Ltd	Optically active pyridone-carboxylic acid compound

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 10, no. 43 (C - 329) 20 February 1986 (1986-02-20) *
PATENT ABSTRACTS OF JAPAN vol. 13, no. 579 (C - 668) 20 December 1989 (1989-12-20) *
PATENT ABSTRACTS OF JAPAN vol. 14, no. 322 (C - 0739) 10 July 1990 (1990-07-10) *
See also references of WO9310785A1 *
T. UNE ET AL.: "IN VITRO ACTIVITY OF DR-3355, AN OPTICALLY ACTIVE OFLOXACIN", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 32, no. 9, 1988, pages 1336 - 1340 *

Also Published As

Publication number	Publication date
AU3147493A (en)	1993-06-28
EP0614364A1 (en)	1994-09-14
AU1515197A (en)	1997-05-22
JPH07503457A (en)	1995-04-13
WO1993010785A1 (en)	1993-06-10
CA2124443A1 (en)	1993-06-10

Legal Events

Date	Code	Title	Description
1994-07-29	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1994-09-14	17P	Request for examination filed	Effective date: 19940624
1994-09-14	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1994-10-19	A4	Supplementary search report drawn up and despatched	Effective date: 19940829
1994-10-19	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1998-04-15	17Q	First examination report despatched	Effective date: 19980303
2001-10-10	GRAG	Despatch of communication of intention to grant	Free format text: ORIGINAL CODE: EPIDOS AGRA
2001-10-10	RIC1	Information provided on ipc code assigned before grant	Free format text: 7A 61K 31/495 A, 7A 61P 31/04 B
2002-09-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED
2002-10-30	18R	Application refused	Effective date: 20020610

Publication	Publication Date	Title
EP0604433A4 (en)	1994-10-12	Composition and method for disease treatment.
GB9208339D0 (en)	1992-06-03	Treatment composition
GB9127150D0 (en)	1992-02-19	Novel treatment
AU644245B2 (en)	1993-12-02	Hair treatment composition
EP0596962A4 (en)	1997-01-15	Therapeutic compositions and methods.
AU2649092A (en)	1993-05-03	Desulphurisation treatment
EP0700292A4 (en)	1996-09-11	Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
GB9024928D0 (en)	1991-01-02	Novel treatment
GB9226958D0 (en)	1993-02-17	Produktionsaktieselskab) novel treatment
EP0614364A4 (en)	1994-10-19	Methods and compositions for treating infection using optically pure (s)-lomefloxacin.
AU7366591A (en)	1991-10-03	Method and composition for water treatment
GB2261432B (en)	1995-03-29	Treatment plant
GB2256237B (en)	1995-08-23	Treatment plant
AU7998691A (en)	1992-01-07	Compositions for treating hiv-type 1 infection
AU2595692A (en)	1993-05-03	Hair treatment composition
PH31066A (en)	1998-02-05	Treatment composition.
GB9024926D0 (en)	1991-01-02	Novel treatment
GB9024925D0 (en)	1991-01-02	Novel treatment
GB9105560D0 (en)	1991-05-01	Novel treatment i
GB9004943D0 (en)	1990-05-02	Dental compositions,procedure and method
GB9010163D0 (en)	1990-06-27	Novel treatment i
GB9113038D0 (en)	1991-08-07	Novel treatment and compositions
EP0760660A4 (en)	1997-07-30	Treating conditions using optically pure(-)-liarozole
GB9006081D0 (en)	1990-05-16	Treatment system
GB9111188D0 (en)	1991-07-17	Novel treatment